Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Copyright, Project CBD. And it’s not just ringing. May not be reprinted without permission.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. For more information, visit www.mymd.com.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

The Cannigma

JUNE 15, 2021

Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. For more information, visit www.mymd.com.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

NOVEMBER 25, 2021

CBD is all the rage, and has been for quite some time. Most cannabis by-products are legal these days, and the CBD industry has been booming. Here are a few reasons why CBD products are more popular than ever this year. Epilepsy Treatment. However, hope in the form of CBD seems to be on the way.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Cannabis Law Report

DECEMBER 28, 2021

This is all thanks to CBD, or cannabidiol, one of the most important cannabinoids identified in cannabis plants. But what makes CBD different from other cannabinoids is its therapeutic properties. So, no wonder CBD-related products are everywhere in the form of tinctures, gummies, oil, cosmetics, and a lot more.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. These effects are shared by THC and CBD, but are typically less potent. However the combination of CBN and CBD produced longer-lasting results, supporting the entourage effect theory.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

SEPTEMBER 22, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. Watch how Supera-CBD works. “We Chief Scientific Officer of MyMD. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. How much does CBD cost in Japan? Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 99

CBD DEA Research and Development Hemp 99

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

AUGUST 19, 2021

Here we’re just talking about CBD. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

The Joint Blog

APRIL 22, 2022

Cannabidiol, also popularly known as CBD, is a chemical compound derived from cannabis Sativa plants. However, before consuming CBD in any form, you must seek your doctor’s advice and buy the best CBD oil on the market. Many companies offer CBD oil in multiple forms for general use. Forms of CBD. Treats Epilepsy.

Oil 26

Oil CBD Topical Clinical Trials 26

Cannabis Law Report

AUGUST 24, 2021

The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Based on a novel synthetic derivative of cannabidiol (CBD), Supera-CBD is being developed to address the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

While CBN is a cannabinoid like THC and CBD, it has different traits, effects, and properties than THC and CBD. THC and CBD are two common cannabinoid names, but they aren’t the only compounds found in the cannabis plant. While CBN is a cannabinoid, it is not as well-known as THC and CBD. Q: Is CBN Safe to Use With CBD?

Sleep 94

Sleep Cannabinoids THC CBD 94

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

United Patients Group

JANUARY 8, 2023

Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Cannabis has been shown to be an effective treatment for a variety of conditions caused by bacteria, viruses and fungi. Ancient Chinese texts and Ayurvedic texts describe its use to treat inflammation, pain and spasms.

Blood Pressure 105

Blood Pressure Sleep Cannabinoids Clinical Trials 105

Cannabis Law Report

OCTOBER 19, 2021

will discuss the multiple indications for each of MyMD’s novel drug candidates, MYMD-1 and Supera-CBD. MyMD expects to launch two Phase 2 trials during the current quarter for MYMD-1 – one for delaying aging and prolonging healthy lifespan, and the other for post- COVID-19 depression and cytokine elevation. About Supera-CBD.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

OCTOBER 5, 2021

will discuss the Company’s product pipeline with diversified indications for MYMD-1 as an immunometabolic regulator and Supera-CBD as a synthetic CBD derivative. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. and Chief Scientific Officer Adam Kaplin, M.D.,

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

Cannabis Law Report

DECEMBER 1, 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator MYMD-1 and synthetic cannabidiol derivative Supera-CBD. During the conferences, MyMD executives will discuss the multiple indications being pursued and market opportunities for novel drug candidates MYMD-1 and Supera-CBD. About Supera-CBD.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

AUGUST 26, 2019

Over the years, research has generated results to suggest that marijuana benefits in the treatment of some conditions. This CBD-based drug is called Epidiolex. This CBD-based drug is called Epidiolex. CBD occurs in cannabis. The drug for treating such conditions involves a purified form of CBD. Chronic pain.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Chronic pain. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Veriheal

APRIL 11, 2022

Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. CBD is also contained in another FDA-approved medicine called Epidiolex®.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. Dr. Chapman Bio. Chapman has operated Chapman Pharmaceutical Consulting, Inc.,

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

More than half the states in the country have now legalized medical cannabis for patients with qualifying conditions and several more have gone so far as to legalize recreational marijuana for adults. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Miss Marijuana

MARCH 15, 2021

The world of CBD flowers has brought a whole new avenue of treatment to medicine. This strain was one of the first high-CBD flowers, and is highly coveted for the positive benefits it provides. Although there are some phenotypes that have higher THC percentages, this flower is bursting with a high percentage of CBD. Common Use.

Strains 52

Strains Indica Sativa Hybrid 52

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Preliminary research findings indicate no benefit for depression from high delta-9 tetrahydrocannabinol (THC) therapeutics, or for CBD in mania.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Cannabis Law Report

NOVEMBER 16, 2021

As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Cannigma

AUGUST 26, 2021

In addition, as of early 2021 , it is legal to purchase CBD oil over the counter in Australia. Qualifying conditions for medical marijuana. These products can only be accessed through the Special Access Scheme by an authorized healthcare practitioner, or as part of a clinical trial, according to the Office of Drug Control.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

NOVEMBER 23, 2021

MyMD also holds two patents for its synthetic cannabidiol (CBD) derivative Supera-CBD. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. The latest patent adds to MyMD’s intellectual property portfolio of 14 granted patents (12 U.S. About MYMD-1.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

AUGUST 19, 2019

Additionally, doctors generally do not feel well-educated around the use of medicinal cannabis products, with specialists often feeling that there is inadequate evidence to support their use in specific conditions. In Australia, drugs that doctors prescribe conventionally have obtained ‘registration’ with the TGA.

Medicine 45

Medicine Patients Clinical Trials Access 45